BOROSCIBSEBorosil Scientific LtdHighNeutral
Announced Wed, 20 May · 14:46 IST

Outcome for Board Meeting held on May 20, 2026 For The Quarter And Financial Year Ended March 31, 2026

Pat Growth 25pctExceptional ItemResults View source PDF

BOROSCI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+18.7%1-day move
₹119.60
prior close
₹123.48
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+15.2+13.9+13.6+16.0+18.7+16.2+15.3+18.8+25.0+25.5+27.1+28.8+35.1
Up moveDown movePending
AI summary

Borosil Scientific Limited reported audited standalone revenue of Rs. 4,275 crore for FY26, up 8.9% from Rs. 3,925 crore in FY25. Standalone PAT grew 13.4% to Rs. 397 crore from Rs. 350 crore. Consolidated PAT showed stronger growth at 29.4%, rising to Rs. 346 crore from Rs. 267 crore. The company received an unmodified (clean) audit opinion from Chaturvedi & Shah LLP. The Board authorized raising funds up to Rs. 250 crore via QIP, FPO, FCCBs or other methods. CEO Vinayak Patankar was reappointed for 3 years from December 2026. Company Secretary Sanjay Gupta resigned and Ramavtar Sharma was appointed effective May 21, 2026. Exceptional items of Rs. 852.82 lakhs were recorded for VRS settlement and labour code impact.

Likely market impact

The strong PAT growth of nearly 30% on consolidated basis and clean audit opinion are positive signals for investors. The Rs. 250 crore fund-raising authorization provides flexibility for future growth plans. Leadership continuity with CEO reappointment is reassuring.